Summary
REVENUES at Irish clinical trials services firm Icon surged by 37pc last year to $865m as it took advantage of the global drugs giants' search for the next blockbuster treatment.
That sent its full-year net income surging to $78.12m or $1.30 per share from $55.96m or $0.94 per share the previous year, while its full-year 2008 operating income rose by an impressive 44pc to $99.5m.See the full content of this document
Extract
Icon Hails 37pc Rise in Revenue [Eire Region]
Net profits grew by 39pc to $78.1m as revenues in the final quarter of the year increased by almost 22pc t...
See the full content of this document
Sponsored links
